These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30325769)

  • 1. The effect of primary drug resistance on CD4+ cell decline and the viral load set-point in HIV-positive individuals before the start of antiretroviral therapy.
    Schultze A; Torti C; Cozzi-Lepri A; Vandamme AM; Zazzi M; Sambatakou H; De Luca A; Geretti AM; Sonnerborg A; Ruiz L; Monno L; Di Giambenedetto S; Gori A; Lapadula G;
    AIDS; 2019 Feb; 33(2):315-326. PubMed ID: 30325769
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High Prevalence of Drug Resistance Mutations Among Patients Failing First-Line Antiretroviral Therapy and Predictors of Virological Response 24 Weeks After Switch to Second-Line Therapy in São Paulo State, Brazil.
    Matsuda EM; Coelho LPO; Romero GF; de Moraes MJ; Lopez-Lopes GIS; Morejon K; Campeas AE; Cabral GB; Brígido LFM
    AIDS Res Hum Retroviruses; 2018 Feb; 34(2):156-164. PubMed ID: 28969448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The association between detected drug resistance mutations and CD4
    Schultze A; Paredes R; Sabin C; Phillips AN; Pillay D; Mackie N; Castagna A; Chadwick D; Falconer K; Geretti AM; Post FA; Hill T; Kirk O; Pozniak A; Nelson M; Tostevin A; Dunn D; Lundgren J; Cozzi-Lepri A
    Antivir Ther; 2018; 23(2):105-116. PubMed ID: 28627486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transmitted drug resistance, selection of resistance mutations and moderate antiretroviral efficacy in HIV-2: analysis of the HIV-2 Belgium and Luxembourg database.
    Ruelle J; Roman F; Vandenbroucke AT; Lambert C; Fransen K; Echahidi F; Piérard D; Verhofstede C; Van Laethem K; Delforge ML; Vaira D; Schmit JC; Goubau P
    BMC Infect Dis; 2008 Feb; 8():21. PubMed ID: 18304321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug resistance-associated genotypic alterations in the pol gene of HIV type 1 isolates in ART-naive individuals in North India.
    Arora SK; Gupta S; Toor JS; Singla A
    AIDS Res Hum Retroviruses; 2008 Feb; 24(2):125-30. PubMed ID: 18240959
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology of primary drug resistance in chronically HIV-infected patients in Nordrhein-Westfalen, Germany, 2001-2005].
    Oette M; Kaiser R; Däumer M; Fätkenheuer G; Rockstroh JK; Knechten H; Mitrenga D; Beerenwinkel N; Sagir A; Pfister H; Häussinger D
    Dtsch Med Wochenschr; 2007 May; 132(18):977-82. PubMed ID: 17457780
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV genotypic resistance testing to optimize antiretroviral prescribing: is there room for improvement?
    Uy J; Brooks JT; Baker R; Hoffman M; Moorman A; Novak R;
    Antivir Ther; 2007; 12(6):957-62. PubMed ID: 17926650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impaired CD4+ cell recovery during antiretroviral therapy in patients with HIV resistance mutations.
    Sühs KW; Stoll M; Diem R; Schmidt RE; Heiken H
    Arch Virol; 2012 Mar; 157(3):433-40. PubMed ID: 22179846
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
    Kebe K; Thiam M; Diagne Gueye NR; Diop H; Dia A; Signate Sy H; Charpentier C; Belec L; Mboup S; Toure Kane C
    AIDS Res Hum Retroviruses; 2013 Feb; 29(2):242-9. PubMed ID: 22860571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of drug resistance on viral load in patients failing antiretroviral therapy.
    Machouf N; Thomas R; Nguyen VK; Trottier B; Boulassel MR; Wainberg MA; Routy JP
    J Med Virol; 2006 May; 78(5):608-13. PubMed ID: 16555280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Limited increase in primary HIV-1C drug resistance mutations in treatment naïve individuals in Ethiopia.
    Huruy K; Maier M; Mulu A; Liebert UG
    J Med Virol; 2015 Jun; 87(6):978-84. PubMed ID: 25649964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-resistant mutants of HIV-1 in patients exhibiting increasing CD4 cell count despite virological failure of highly active antiretroviral therapy.
    Antinori A; Liuzzi G; Cingolani A; Bertoli A; Di Giambenedetto S; Trotta MP; Rizzo MG; Girardi E; De Luca A; Perno CF
    AIDS; 2001 Nov; 15(17):2325-7. PubMed ID: 11698709
    [No Abstract]   [Full Text] [Related]  

  • 13. Long-term immunologic and virologic responses in patients with highly resistant HIV infection who are treated with an incompletely suppressive antiretroviral regimen.
    Gandhi T; Nagappan V; Cinti S; Wei W; Kazanjian P
    Clin Infect Dis; 2007 Oct; 45(8):1085-92. PubMed ID: 17879930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human immunodeficiency virus type 1 (HIV-1) genotyping in Rio de Janeiro, Brazil: assessing subtype and drug-resistance associated mutations in HIV-1 infected individuals failing highly active antiretroviral therapy.
    Couto-Fernandez JC; Silva-de-Jesus C; Veloso VG; Rachid M; Gracie RS; Chequer-Fernandez SL; Oliveira SM; Arakaki-Sanchez D; Chequer PJ; Morgado MG
    Mem Inst Oswaldo Cruz; 2005 Feb; 100(1):73-8. PubMed ID: 15867968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genotypic resistance and HIV-1 subtype in Brazilian children on dual and triple combination therapy.
    Machado ES; Lambert JS; Watson DC; Afonso AO; da Cunha SM; Nogueira SA; Caride E; Oliveira RH; Sill AM; DeVico A; Tanuri A
    J Clin Virol; 2004 May; 30(1):24-31. PubMed ID: 15072750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-1 Antiretroviral Resistance in Cuba, 2009-2014.
    Alemán-Campos Y; Kourí-Cordellá V; Pérez-Santos L; Fonseca-Gómez C; Pérez-Ávila J; Ortega-González LM; Baños-Morales Y; Álvarez-López A; Correa-Sierra CB; Martínez-Montesinos Y; Soto-Brito Y; Limia-León CM; Campos-Díaz JR; Caturla-Fernández Y; Alvarez-Gainza D; Pintos-Saavedra Y; Añé-Kourí AL; Joanes-Fiol J
    MEDICC Rev; 2018 Jul; 20(3):15-21. PubMed ID: 31242157
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiretroviral drug resistance in a respondent-driven sample of HIV-infected men who have sex with men in Brazil.
    Bermúdez-Aza EH; Kerr LR; Kendall C; Pinho AA; de Mello MB; Mota RS; Guimarães MD; Alencar CS; de Brito AM; Dourado IC; da Batista SM; Abreu F; de Oliveira LC; de Souza Moraes A; Benzaken AS; Merchan-Hamann E; de Freitas GM; McFarland W; Albuquerque E; Rutherford GW; Sabino E
    J Acquir Immune Defic Syndr; 2011 Aug; 57 Suppl 3():S186-92. PubMed ID: 21857316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of Drug Resistance Associated Mutations Among the Anti Retroviral Therapy Exposed HIV-1 Infected Individuals in Manipur, Northeast India.
    Lakhikumar Sharma A; Ramsing Singh T; Ranjana Devi K; Shanjukumar Singh L
    Curr HIV Res; 2016; 14(4):360-70. PubMed ID: 27033350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lability of antiretroviral drug resistance mutations--correlates with immunological and virological responses.
    Al Mazari A; Zomaya AY; Charleston M; Salem H; Maher A; Garsia RJ
    Curr HIV Res; 2007 Jul; 5(4):430-9. PubMed ID: 17627506
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term analysis of the resistance development in HIV-1 positive patients treated with protease and reverse transcriptase inhibitors: correlation of the genotype and disease progression.
    Václavíková J; Weber J; Machala L; Reinis M; Linka M; Brůcková M; Vandasová J; Stanková M; Konvalinka J
    Acta Virol; 2005; 49(1):29-36. PubMed ID: 15929396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.